Patents by Inventor Olaf WELTING

Olaf WELTING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEUROMODULATION DEVICE
    Publication number: 20210393949
    Abstract: The invention provides devices, apparatuses, systems and methods for treating and ameliorating inflammation of the gut. In particular, the invention provides devices, apparatuses and methods in which a neuromodulatory signal is delivered a splenic nerve and/or superior mesenteric plexus (SMP). The signal is able to treat inflammatory disorders, e.g., colitis, for example in Inflammatory Bowel Disease.
    Type: Application
    Filed: February 26, 2021
    Publication date: December 23, 2021
    Applicants: GALVANI BIOELECTRONICS LIMITED, ACADEMISCH MEDISCH CENTRUM
    Inventors: Daniel John CHEW, Wouter Jacob DE JONGE, Hans Jakob Kristoffer FAMM, Sonal PATEL, Olaf WELTING
  • Neuromodulation device
    Patent number: 10974041
    Abstract: The invention provides devices, apparatuses, systems and methods for treating and ameliorating inflammation of the gut. In particular, the invention provides devices, apparatuses and methods in which a neuromodulatory signal is delivered a splenic nerve and/or superior mesenteric plexus (SMP). The signal is able to treat inflammatory disorders, e.g., colitis, for example in Inflammatory Bowel Disease.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: April 13, 2021
    Assignees: GALVANI BIOELECTRONICS LIMITED, ACADEMISCH MEDISCH CENTRUM
    Inventors: Daniel John Chew, Wouter Jacob De Jonge, Hans Jakob Kristoffer Famm, Sonal Patel, Olaf Welting
  • NEUROMODULATION DEVICE
    Publication number: 20180117319
    Abstract: The invention provides devices, apparatuses, systems and methods for treating and ameliorating inflammation of the gut. In particular, the invention provides devices, apparatuses and methods in which a neuromodulatory signal is delivered a splenic nerve and/or superior mesenteric plexus (SMP). The signal is able to treat inflammatory disorders, e.g., colitis, for example in Inflammatory Bowel Disease.
    Type: Application
    Filed: April 22, 2016
    Publication date: May 3, 2018
    Applicants: GALVANI BIOELECTRONICS LIMITED, ACADEMISCH MEDISCH CENTRUM
    Inventors: Daniel John CHEW, Wouter Jacob DE JONGE, Hans Jakob Kristoffer FAMM, Sonal PATEL, Olaf WELTING